Efficacy and Safety of Xiangjurupining Capsule for Hyperplasia of Mammary Glands
Clinical trial NCT06685978 · RECRUITING
Trial details
- NCT number
- NCT06685978
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-26
- Primary completion
- 2026-04-30
- Enrollment
- 430
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.